TOP STORIES
Artificial womb technology is advancing. Explore how gestational biobags could reshape neonatal care, parenthood, abortion debates, and bioethics.
📈 TRENDING
FOLLOW US ON YOUTUBE
SUBSCRIBE TO OUR SUBSTACK
FROM THE EDITOR'S DESK
Meg Samek-Smith, co-founder, CEO, and Editor-in-Chief of Genomics Media Group (GMG)
In the future, you don't pick a roast anymore because your coffee is genomically tailored to you. At Genomics Media Group, we track where genomics turns science into economic value, and coffee may be one of the most revealing—and investible—examples of how that happens.
I'm Meg Samek-Smith, co-founder, CEO, and Editor-in-Chief of Genomics Media Group (GMG). Over the past several years, I’ve had the privilege of working in the genomics world—on both the lab side and in developing an RNA and AI-enable screening tool.
Thank you for joining our mission to advance the business of genomics—treating DNA as a platform technology projected to grow from $44 billion in 2025 to $175 billion by 2034. We chronicle how genomic insights become products, markets, and returns across people, plants, and animals in what we call the genomics economy.
BEST OF GMG
Discover how genetic engineering is paving the way for the first de-extinction zoo, with Colossal Biosciences leading the charge to revive extinct animals and create a modern Jurassic Park.
TOP STORIES

